Inhibitive effect of dominant negative human epidermal growth factor receptor on the invasion and metastasis of gastric cancer cells
返回论文页
|更新时间:2023-12-18
|
Inhibitive effect of dominant negative human epidermal growth factor receptor on the invasion and metastasis of gastric cancer cells
Journal of Chongqing Medical UniversityVol. 37, Issue 7, Pages: 574-578(2012)
作者机构:
1. 重庆医科大学附属第一医院1. 胃肠外科
2. 实验研究中心,重庆,400016
作者简介:
基金信息:
DOI:
CLC:
Published:2012,
扫 描 看 全 文
LIAO Gang, WANG Ziwei, ZHANG Neng, et al. Inhibitive effect of dominant negative human epidermal growth factor receptor on the invasion and metastasis of gastric cancer cells. [J]. Journal of Chongqing Medical University 37(7):574-578(2012)
DOI:
LIAO Gang, WANG Ziwei, ZHANG Neng, et al. Inhibitive effect of dominant negative human epidermal growth factor receptor on the invasion and metastasis of gastric cancer cells. [J]. Journal of Chongqing Medical University 37(7):574-578(2012)DOI:
Inhibitive effect of dominant negative human epidermal growth factor receptor on the invasion and metastasis of gastric cancer cells
Objective:To explore the effect of dominant negative epidermal growth factor receptor(DNEGFR) on the invasion and metastasis of human gastric cancer cells and to elucidate its molecular mechanism. Methods:The pEGFPN1-DNEGFR was construct-ed and human gastric cancer cells were transfected stably. The invasion and metastasis in vitro were tested by Transwell invasion cham-ber assay. Matrix metalloproteinase-2(MMP-2) and Matrix metalloproteinase-9(MMP-9) mRNA levels of cells were detected by re-versed transcription-polymerase chain reaction(RT-PCR). MMP-2 and MMP-9 protein levels of culture were detected by enzyme-linked immunosorbent assay(ELISA). Results:pEGFPN1-DNEGFR was constructed successfully,human gastric cancer cells was transfected stably. MMP-2 and MMP-9 mRNA levels of cells were down-regulated;MMP-2 and MMP-9 protein levels of culture were down-regulated as well. Conclusions:DNEGFR represses the invasion and metastasis of human gastric cancer cells by inhibiting them from secreting MMP-2 and MMP-9,which lays a solid foundation for further research of DNEGFR in gastric cancer biotherapy.